Cited by 276Hepatitis B Virus StudiesHepatitis C virus researchCervical Cancer and HPV Research

The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.

Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma

Kew, M.C.·2010·Pathologie Biologie

DOI 10.1016/j.patbio.2010.01.005

Open this paper in CoChat — free account

Abstract

Approximately 360 million people worldwide are chronically infected with hepatitis B virus (HBV) and are at high risk of developing hepatocellular carcinoma (HCC). Chronic HBV infection is the most prevalent cause of this tumour, accounting for 55% of global cases, and 89% of those in endemic regions for HBV infection. Relative risks for developing HCC in the presence of chronic HBV infection may be as high as 49 in case-control studies, and 98 in cohort studies. HCC is the sixth most common cancer in the world today, with approximately 630,000 new cases occurring each year. It ranks third in annual cancer mortality rates. Approximately 80% of HCCs occur in developing countries where HBV infection is endemic, with the highest incidences being in the Asia-Pacific region, and sub-Saharan Africa. In the chronic carriers of the virus who are at greatest risk of developing HCC, the infection is acquired at birth or in the early months or years of life, either perinatally or horizontally, and frequently becomes chronic. The risks are greater in males, and older individuals, and are increased by co-exposure to aflatoxin B(1), the presence of cirrhosis, obesity, or diabetes mellitus, and possibly co-infection with hepatitis C virus. Viral factors that influence the risk of HCC are high viral load, the presence of certain mutations, and genotypes. Although the incidence of chronic HBV infection is beginning to decrease as a result of the universal infant immunization programme, HBV-induced HCC incidence is projected to increase for at least another two decades.

Integrity signals

Registry

Crossref · 10.1016/j.patbio.2010.01.005

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,710
Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
Hepatocellular carcinoma
Llovet, J. M., Burroughs, A. K., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,637
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
Lavanchy, D. (2004) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00487.x · Cited by 2,649
Primary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Clèries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,473
Hepatitis B Virus Infection — Natural History and Clinical Consequences
Ganem, D., & Prince, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031087 · Cited by 2,361
Viral Hepatitis and Liver Disease
Vyas, G. N., Dienstag, J. L., & Hoofnagle, J. H. (1985) · Medical Entomology and Zoology · Cited by 1,867
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H., Lu, S., Liaw, Y., You, S., Sun, C., Wang, L., Hsiao, C. K., Chen, P., Chen, D., & Chen, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,220
Hepatitis B Virus Infection: Epidemiology and Vaccination
Shepard, C. W. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj009 · Cited by 1,152

Flagged first, then by citations

Show all 63 references

1 of the 63 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

Robinson, 2005, The New Zealand hepatitis B screening programme: screening coverage and prevalence of hepatitis B infection, N Z Med J, 118, U1345
Chia, 1996, Singapore cancer registry report No. 4. Trends in cancer incidence in Singapore 1968–1992, Singapore Cancer Rep, 4, 86
1994, Hepatitis viruses, vol. 59, 66
Kew, 1998, Hepatitis C virus and hepatocellular carcinoma in developing and developed countries, Vir Hepatit Rev, 4, 259

Sorted by citations

Items 101–200 of 276

Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study
da Silva, M. C. A., Miozzo, S. A. D. S., Dossin, I. D. A., Tovo, C. V., Branco, F., & de Mattos, Â. A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i46.10219 · Cited by 24
Solid-Phase Synthesis of the Lipopeptide Myr-HBVpreS/2-78, a Hepatitis B Virus Entry Inhibitor
Schieck, A., Müller, T. H., Schulze, A., Haberkorn, U., Urban, S., & Mier, W. (2010) · Molecules · doi:10.3390/molecules15074773 · Cited by 24
Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma
Baran, B. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i13.1742 · Cited by 23
Is An Oral Plant-based Vaccine against Hepatitis B Virus Possible?
Pniewski, T. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112804724837 · Cited by 22
ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5
Liu, G., Yang, Z., Zhou, P., Zhou, C., Guan, R., Sun, B., Fan, J., Zhou, J., Yi, Y., & Qiu, S. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155004 · Cited by 22
Long‐term survival after surveillance and treatment in patients with chronic viral hepatitis and hepatocellular carcinoma
Tong, M. J., Rosinski, A. A., Huynh, C. T., Raman, S. S., & Lu, D. (2017) · Hepatology Communications · doi:10.1002/hep4.1047 · Cited by 22
Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma
Shi, T., Hua, Q., Ma, Z., & Lv, Q. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.10.020 · Cited by 22
Environmental Exposures and Hepatocellular Carcinoma
Santella, R. M., & Wu, H. (2013) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2013.008xx · Cited by 22
Changing trends in liver cancer incidence by race/ethnicity and sex in the US: 1992–2016
Salvatore, M., Jeon, J., & Meza, R. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01237-4 · Cited by 21
MicroRNA‑601 serves as a potential tumor suppressor in hepatocellular carcinoma by directly targeting PIK3R3
Song, Y., He, S., Zhuang, J., Wang, G., Ni, J., Zhang, S., Ye, Y., & Xia, W. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9857 · Cited by 20
Retracted
Aetiology of viral hepatitis among jaundiced patients presenting to a tertiary hospital in Ghana
Owusu, M., Bonney, J. H. K., Sylverken, A. A., Mawuli, G., Okyere, K., Mutocheluh, M., Aryeequaye, J., Adjei, N. K., Afihene, M., Spangenberg, K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203699 · Cited by 20
Association of HLA-DQ and IFNL4 polymorphisms with susceptibility to hepatitis B virus infection and clearance.
Fan, J., Hou, S.-H., Li, Q., Hu, J., Peng, H., & Guo, J. (2016) · PubMed · doi:10.5604/16652681.1202946 · Cited by 19
Potential biomarkers Ang II/AT1R and S1P/S1PR1 predict the prognosis of hepatocellular carcinoma
Ji, Y., Chen, H., Gow, W., Ma, L., Jin, Y., Hui, B., Yang, Z., & Wang, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.12071 · Cited by 19
Evaluation for the Genetic Association between Store-Operated Calcium Influx Pathway (STIM1 and ORAI1) and Human Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection
Irham, L. M., Chou, W., Wang, Y., Adikusuma, W., Wong, H. S.-C., Perwitasari, D. A., Huang, W., Chen, B., Yang, H., & Chang, W. (2020) · Biology · doi:10.3390/biology9110388 · Cited by 19
Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission—A review of maternal and infant outcomes
Kochaksaraei, G. S., Shaheen, A. A., Seow, C. H., Barkema, H. W., & Coffin, C. S. (2022) · Liver International · doi:10.1111/liv.15249 · Cited by 19
Comparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinoma
Soyemi, O. M., Otegbayo, J. A., Ola, S. O., Akere, A., & Soyemi, T. O. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-403 · Cited by 19
Design and synthesis of pyridine-pyrazole-sulfonate derivatives as potential anti-HBV agents
Chuang, H., Huang, L.-C. S., Kapoor, M., Liao, Y., Yang, C.-L., Chang, C., Wu, C., Hwu, J. R., Huang, T., & Hsu, M.-H. (2016) · MedChemComm · doi:10.1039/c6md00008h · Cited by 19
Risk factors and survival outcomes of biliary complications after adult-to-adult living donor liver transplantation
Jeong, S., Wang, X., Wan, P., Sha, M., Zhang, J., Xia, L., Tong, Y., Luo, Y., & Xia, Q. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640616688994 · Cited by 19
Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma
Zheng, H., Zou, A. E., Saad, M. A., Wang, X. Q., Kwok, J. G., Korrapati, A., Li, P. X., Kisseleva, T., Wang‐Rodriguez, J., & Ongkeko, W. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178547 · Cited by 19
Strategies for the treatment of HBV/HDV
Krause, A., Haberkorn, U., & Mier, W. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.030 · Cited by 19
Plant-based vaccines and cancer therapy: Where are we now and where are we going?
Rahimian, N., Miraei, H. R., Amiri, A., Ebrahimi, M. S., Nahand, J. S., Tarrahimofrad, H., Hamblin, M. R., Khan, H. Z., & Mirzaei, H. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105655 · Cited by 19
p53 Mutation at Serine 249 and Its Gain of Function Are Highly Related to Hepatocellular Carcinoma after Smoking Exposure
Wang, H., Lu, C., Zhou, T., Zhang, Z., & Zeng, C. (2021) · Public Health Genomics · doi:10.1159/000516598 · Cited by 19
E3 Ubiquitin Ligase Siah-1 is Down-regulated and Fails to Target Natural HBx Truncates for Degradation in Hepatocellular Carcinoma
Zhao, J., Wu, J., Cai, H., Wang, D., Yu, L., & Zhang, W. (2016) · Journal of Cancer · doi:10.7150/jca.13019 · Cited by 19
The Pretreatment Platelet Count is an Independent Predictor of Tumor Progression in Patients Undergoing Transcatheter Arterial Chemoembolization with Hepatitis B Virus-Related Hepatocellular Carcinoma
Wang, B., Li, F., Cheng, L., Zhan, Y., Wu, B., Chen, P., Shen, J., Wu, W., Ma, X., Zhu, J., et al. (2019) · Future Oncology · doi:10.2217/fon-2018-0591 · Cited by 19
Hepatitis B Vaccines
Damme, P. V., Ward, J. W., Shouval, D., & Zanetti, A. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00025-0 · Cited by 20
Hepatitis B Virus / Human Immunodeficiency Virus Co-Infection and Its Hepatocarcinogenic Potential in Sub-Saharan Black Africans
Kew, M. C. (2012) · Hepatitis Monthly · doi:10.5812/hepatmon.7876 · Cited by 18
Self-citation
Cohort profile: golestan hepatitis B cohort study- a prospective long term study in northern iran .
Poustchi, H., Katoonizadeh, A., Ostovaneh, M. R., Moossavi, S., Sharafkhah, M., Esmaili, S., Pourshams, A., Mohamadkhani, A., Besharat, S., Merat, S., et al. (2014) · Europe PMC (PubMed Central) · Cited by 18
A Literature Review on the Antiviral Mechanism of Luteolin
Lu, P., Zhang, T., Ren, Y., Rao, H., Lei, J., Zhao, G., Wang, M., Gong, D., & Cao, Z. (2023) · Natural Product Communications · doi:10.1177/1934578x231171521 · Cited by 19
Association Between IL-10 Gene Promoter Polymorphism and Hepatitis B Viral Infection in an Egyptian Population
Talaat, R. M., Dondeti, M. F., El-Shenawy, S. Z., & Khamiss, O. (2014) · Biochemical Genetics · doi:10.1007/s10528-014-9655-8 · Cited by 18
Evaluation of the Impact of Hepatitis B Vaccination in Adults in Jiangsu Province, China
Zhu, L., Zhai, X., Zhu, Y., Xu, W., Bao, C., Peng, X., Bian, Q., Yang, H., Wang, H., Hu, Z., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101501 · Cited by 18
Cytotoxic, caspase-3 induction and in vivo hepatoprotective effects of phyllanthin, a major constituent of Phyllanthus niruri
Ooi, K. L., Loh, S. I., Sattar, M. Z. A., Muhammad, T. S. T., & Sulaiman, S. F. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.01.032 · Cited by 18
Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma with magnetic bead-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Liu, T., Xue, R., Huang, X., Zhang, D., Dong, L., Wu, H., & Shen, X. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr044 · Cited by 18
Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring
Khamduang, W., Gaudy‐Graffin, C., Ngo‐Giang‐Huong, N., Jourdain, G., Moreau, A., Borkird, T., Layangool, P., Kamonpakorn, N., Jitphiankha, W., Kwanchaipanich, R., et al. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.06.025 · Cited by 18
Cancer-Associated Infectious Agents and Epigenetic Regulation
Vedham, V., & Verma, M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1804-1_18 · Cited by 18
MicroRNA-214 targets Wnt3a to suppress liver cancer cell proliferation
Yang, Y., Zhao, Z., Hou, N., Li, Y., Wang, X., Wu, F., Sun, R., Han, J., Sun, H., Song, T., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7483 · Cited by 18
GSK-3β suppresses HCC cell dissociation in vitro by upregulating epithelial junction proteins and inhibiting Wnt/β-catenin signaling pathway
Zhang, J., Jiao, L.-Y., Li, T., Zhu, Y. Y., Zhou, J., & Tian, J. (2017) · Journal of Cancer · doi:10.7150/jca.18744 · Cited by 17
Natural Products Mediated Targeting of Virally Infected Cancer
Fatima, I., Kanwal, S., & Mahmood, T. (2019) · Dose-Response · doi:10.1177/1559325818813227 · Cited by 16
Diagnostic value of circulating microRNAs for hepatocellular carcinoma
Yang, Y., & Zhu, R. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3578-7 · Cited by 16
Hepatitis B virus X protein increases the IL-1β-induced NF-κB activation via interaction with evolutionarily conserved signaling intermediate in Toll pathways (ECSIT)
Chen, W.-N., Liu, L., Jiao, B., Lin, W., Lin, X., & Lin, X. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.025 · Cited by 16
HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma
Liu, X., Zhang, Y., Wang, P., Wang, H., Su, H., Zhou, X., & Zhang, L. (2016) · Medical Science Monitor · doi:10.12659/msm.895943 · Cited by 16
Liver cirrhosis mortality at national and provincial levels in Iran between 1990 and 2015: A meta regression analysis
Rezaei, N., Asadi‐Lari, M., Sheidaei, A., Khademi, S., Gohari, K., Delavari, F., Delavari, A., Abdolhamidi, E., Chegini, M., Rezaei, N., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0198449 · Cited by 17
Probabilistic dietary based estimation of the burden of aflatoxin-induced hepatocellular carcinoma among adult Malawians
Matumba, L., Kimanya, M. E., Chunga-Sambo, W., Munthali, M., & Ayalew, A. (2019) · World Mycotoxin Journal · doi:10.3920/wmj2018.2346 · Cited by 16
PDK1‑WNK1 signaling is affected by HBx and involved in the viability and metastasis of hepatic cells
Li, Z., Lin, C., Cong, X., & Jiang, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.8001 · Cited by 16
Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder
Meng, Y., Jiang, B., Yan, K., Wang, S., Zhang, Z., Chen, L., Wu, W., & Yang, W. M. (2023) · International Journal of Hyperthermia · doi:10.1080/02656736.2023.2182748 · Cited by 15
The Tumor Necrosis Factor-α-308 and -238 Polymorphisms and Risk of Hepatocellular Carcinoma for Asian Populations: A Meta-Analysis
Hu, Q., Lou, G.-G., Liu, Y., Qian, L., & Lv, B. (2014) · Current Therapeutic Research · doi:10.1016/j.curtheres.2014.04.001 · Cited by 15
LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA
Sá, G. P. D., Vicentine, F. P. P., Netto, A. A. S., de Matos, C. A. L., ROMERO, L. R., Tejada, D. F. P., Massarollo, P. C. B., Filho, G. D. J. L., & Gonzalez, A. M. (2016) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-6720201600040007 · Cited by 15
High platelet count predicts poor prognosis in HCC patients undergoing TACE: a propensity score-matched analysis
Li, S., Cao, D., He, J., Lou, M.-G., Tu, X.-X., & Li, Y. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2031977 · Cited by 15
The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma
Pang, Q., Zhang, J., Xu, X., Song, S., Chen, W., Zhou, Y., Miao, R., Qu, K., Liu, S., Dong, Y., et al. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.981759 · Cited by 15
Effects of interaction between genetic variants in human leukocyte antigen DQ and granulysin genes in Chinese Han subjects infected with hepatitis B virus
Hou, S.-H., Hu, J., Zhang, Y., Li, Q., & Guo, J. (2015) · Microbiology and Immunology · doi:10.1111/1348-0421.12239 · Cited by 15
Psychosocial Predictors of HBV Screening Behavior among Vietnamese Americans
Lee, M., Zhu, L., Wang, M. Q., Wei, Z., Tan, Y., Nguyen, M. T., Ogunwobi, O. O., & Grace, X. (2017) · American Journal of Health Behavior · doi:10.5993/ajhb.41.5.5 · Cited by 14
Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience
Mehinović, L., Islamagić, E., Husić-Selimović, A., Kurtović-Kozarić, A., Vukobrat-Bijedić, Z., & Suljević, D. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.344 · Cited by 14
Hepatitis B vaccines
Damme, P. V., Ward, J., Shouval, D., Wiersma, S., & Zanetti, A. R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00025-2 · Cited by 14
New insights on hepatocellular carcinoma: epidemiology and clinical aspects
Puoti, C. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.67 · Cited by 14
The Double-Edged Sword Role of Viruses in Gastric Cancer
Niedźwiedzka‐Rystwej, P., Grywalska, E., Hrynkiewicz, R., Wołącewicz, M., Becht, R., & Roliński, J. (2020) · Cancers · doi:10.3390/cancers12061680 · Cited by 15
Surveillance of hepatocellular carcinoma by medical imaging
Dietrich, C. F., Teufel, A., Sirlin, C. B., & Dong, Y. (2019) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2019.10.04 · Cited by 13
Inhibition of Hepatitis B Virus and Induction of Hepatoma Cell Apoptosis by ASGPR-Directed Delivery of shRNAs
Ma, J., Huang, C., XinXin, Y., Shi, C., Sun, L., Yuan, L., Lei, P., Zhu, H., Liu, H., Wu, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046096 · Cited by 13
Characteristics of Liver Cancer at Khmer-Soviet Friendship Hospital in Phnom Penh, Cambodia
Narin, P., Hamajima, N., Kouy, S., Hirosawa, T., & Eav, S. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.1.35 · Cited by 13
High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit
Bert, F., Rindermann, A., Abdelfattah, M. A., Stahmeyer, J. T., & Rossol, S. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000702 · Cited by 13
Hepatocellular Carcinoma in India
Chavda, H. (2021) · Indian Journal of Surgery · doi:10.1007/s12262-021-02762-w · Cited by 13
The Effect of Ferroptosis-Related Genes on Prognosis and Tumor Mutational Burden in Hepatocellular Carcinoma
Zhang, H., Liu, R., Sun, L., Guo, W., & Hu, X. (2021) · Journal of Oncology · doi:10.1155/2021/7391560 · Cited by 12
Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs
Gibson, E. A., Goldman, R. E., & Culp, W. T. N. (2022) · Veterinary Sciences · doi:10.3390/vetsci9090489 · Cited by 12
HBx and HBs regulate RhoC expression by upregulating transcription factor Ets-1
Qin, D., Li, K., Qu, J., Wang, S., Zou, C., Sheng, Y., Huang, A., & Tang, H. (2013) · Archives of Virology · doi:10.1007/s00705-013-1655-1 · Cited by 12
Serological and virological markers of nigerian patients with hepatitis B infection
Lesi, O. A., Audu, R., Okwuraiwe, A. P., Adeleye, O. O., Ige, F. A., & Iwuorah, J. C. (2019) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_273_17 · Cited by 12
MicroRNA-520a suppresses HBV replication in HepG2.2.15 cells by inactivating AKT
Sun, W., Zhang, J., & Chen, J. (2018) · Journal of International Medical Research · doi:10.1177/0300060518792780 · Cited by 11
Diagnostic accuracy of midkine for hepatocellular carcinoma: A meta‐analysis
Zhang, Y., Tang, J., Zhou, X., Zhu, S., & Li, L. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1071 · Cited by 11
Hepatocellular Carcinoma
Kew, M. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-18257-5_34 · Cited by 11
Self-citation
Liver Injury Induced by High-Dose Methylprednisolone Therapy: A Case Report and Brief Review of the Literature
Gutkowski, K., Chwist, A., & Hartleb, M. (2011) · Hepatitis Monthly · doi:10.5812/kowsar.1735143x.707 · Cited by 11
Hepatocellular carcinoma: the rising tide from east to west—a review of epidemiology, screening and tumor markers
Monsour, H., Asham, E. H., McFadden, R., Victor, D. W., Muthuswamy, B., & Zaheer, I. (2013) · Translational Cancer Research · doi:10.21037/1864 · Cited by 10
Comparative study of the different activities of hepatitis B virus whole-X protein and HBx in hepatocarcinogenesis by proteomics and bioinformatics analysis
Zhang, Y., Liu, J., Liu, H., He, Y., Yi, R., Niu, Y., Chen, T., Yang, Q., & Zhao, Y. (2015) · Archives of Virology · doi:10.1007/s00705-015-2421-3 · Cited by 10
Activation of AMPK/MnSOD signaling mediates anti-apoptotic effect of hepatitis B virus in hepatoma cells
Li, L., Hong, H., Chen, S.-P., Ma, C., Liu, H., & Yao, Y. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i17.4345 · Cited by 10
Hepatitis B Virus Antibody Levels in High-Risk Health Care Workers
Nejad, E. M., Jafari, S., Mahmoodi, M., Begjani, J., Ehsani, S. R., & Rabirad, N. (2011) · Hepatitis Monthly · doi:10.5812/kowsar.1735143x.1388 · Cited by 10
Incidence du carcinome hépatocellulaire lors de l’infection chronique par le virus de l’hépatite B
Ntagirabiri, R., Munezero, B., Kaze, H., Ndirahisha, E., & Manirakiza, S. (2015) · Pan African Medical Journal · doi:10.11604/pamj.2015.20.167.6227 · Cited by 10
Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis
Ying, X., Han, S.-X., Wang, J.-L., Zhou, X., Jin, G.-H., Jin, L., Wang, H., Wu, L., Zhang, J., & Zhu, Q. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-130 · Cited by 10
Transmembrane channel‑like protein 8 as a potential biomarker for poor prognosis of hepatocellular carcinoma
Lu, P., Ding, Q., Ding, S., Fan, Y., Li, X., Tian, D., & Liu, M. (2017) · Molecular and Clinical Oncology · doi:10.3892/mco.2017.1285 · Cited by 10
The impact of hepatitis B virus x protein and microRNAs in hepatocellular carcinoma: a comprehensive analysis
Li, L., Yin, X., Hu, X., Wang, Q., & Zheng, L. (2014) · Tumor Biology · doi:10.1007/s13277-014-2658-6 · Cited by 9
Do different lamivudine‐resistant hepatitis B genotypes carry the same risk of entecavir resistance?
Lee, G. H., Aung, M. O., Dan, Y. Y., Lee, Y. M., Mak, B., Low, H. C., Lim, K., Thwin, M. A., Tan, P. S., & Lim, S. G. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23392 · Cited by 9
King’s score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma
Pang, Q., Bi, J., Xu, X., Liu, S., Zhang, J., Zhou, Y., Qu, K., & Liu, C. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000452 · Cited by 9
Potent killing of HBV-related hepatocellular carcinoma by a chimeric protein of anti-HBsAg single-chain antibody and truncated Bid
Yan, B., Ouyang, Q., Zhao, Z., Cao, F., Wang, T., Jia, X., Meng, Y., Jiang, S., Liu, J., Chen, R., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.046 · Cited by 9
Transforming Growth Factor-β1 Gene Polymorphism (T29C) in Egyptian Patients with Hepatitis B Virus Infection: A Preliminary Study
Talaat, R. M., Dondeti, M. F., El-Shenawy, S. Z., & Khamiss, O. (2013) · Hepatitis Research and Treatment · doi:10.1155/2013/293274 · Cited by 9
Unveiling the molecular interaction of hepatitis B virus inhibitor, entecavir with human serum albumin through computational, microscopic and spectroscopic approaches
Abubakar, M., Mohamad, S. B., Halim, A. A. A., & Tayyab, S. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2311331 · Cited by 8
Association between Single‐Nucleotide Polymorphism in MicroRNA Target Site of DDB2 and Risk of Hepatocellular Carcinoma in a Southern Chinese Population
Qiu, M., Liu, Y., Zhou, Z., Jiang, Y., Lin, Q., Huo, R., Liang, X., Yu, X., Zhou, X., & Yu, H. (2020) · BioMed Research International · doi:10.1155/2020/8528747 · Cited by 8
A Functional Insertion/Deletion Polymorphism in the Proximal Promoter of CD3G Is Associated with Susceptibility for Hepatocellular Carcinoma in Chinese Population
Jiang, L., Xu, J., Ni, J., Gao, X., Zhu, Z., Dong, D., Wang, X., Shi, C., Tao, X., Dong, W., et al. (2012) · DNA and Cell Biology · doi:10.1089/dna.2012.1706 · Cited by 8
Chinese medicine syndrome distribution of chronic hepatitis b virus carriers in immunotolerant phase
Xie, H., Yang, H., Wei-kang, W., Guan, W., Ke, Q.-S., Li, Y., Dai, M., Xiao, G., Zhang, J.-S., & Li, Y. (2014) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-013-1569-5 · Cited by 8
Original Research: Analysis of hepatic microRNA alterations in response to hepatitis B virus infection and pegylated interferon alpha-2a treatment
Jinato, T., Chuaypen, N., Poomipak, W., Praianantathavorn, K., Makkoch, J., Kiatbumrung, R., Jampoka, K., Tangkijvanich, P., & Payungporn, S. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216647184 · Cited by 8
CHRONIC VIRAL HEPATITIDES: PAST, PRESENT, FUTURE
Владимирович, Н. В., Леонидович, М. С., Nazarov, V. Y., Пожидаева, Л. Н., & Chakhar'yan, V. V. (2013) · Epidemiology and Infectious Diseases · doi:10.17816/eid40691 · Cited by 8
AFLATOXIN STANDARDS AND MAIZE TRADE
Brankov, T., Jovanovic, M. C., & Grujić, B. (2013) · Ekonomika poljoprivrede · doi:10.22004/ag.econ.158258 · Cited by 8
Migration, Hepatitis B, and Hepatitis C
Carballo, M., Cody, R., Kelly, M., & Hatzakis, A. E. (2013) · doi:10.1002/9781118637272.ch37 · Cited by 8
The impact of HIV infection on clinical presentation and mortality among persons with hepatocellular carcinoma in Kampala, Uganda
Nsibirwa, S. K., Aizire, J., Mugerwa, J. N., Thomas, D. L., Ocama, P., & Kirk, G. D. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08164-5 · Cited by 7
Association of Interleukin 27 gene polymorphism and risk of Hepatitis B viral infection in Egyptian population
Ali, Y. B. M., El-Masry, S. A., El-Akhras, B. A., El-Shenawy, S. Z., & El-Sayed, I. H. (2014) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2013.12.001 · Cited by 7
Identification of dysfunctional biological pathways and their synergistic mechanism in hepatocellular carcinoma process
Liang, J., Lv, J., & Liu, Z. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.03.028 · Cited by 7
Factors related to the quality of life in liver cancer patients during treatment phase: A follow‐up study
Li, I. F., Huang, J., Chen, J.-J., Wang, T. E., Huang, S., & Tsay, S. (2019) · European Journal of Cancer Care · doi:10.1111/ecc.13146 · Cited by 7
Antihepatitis B Virus Activity of a Protein-Enriched Fraction from Housefly ( Musca domestica ) in a Stable HBV-Producing Cell Line
Lu, X., Jin, X., Wang, J., Chu, F., & Zhu, J. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/389560 · Cited by 7
Inhibition of Hepatitis B Virus Replication by a Novel GalNAc–siRNA In Vivo and In Vitro
Zhang, Z., Ma, Y., He, Y., Wang, D., Yue, K., Zhang, X., & Song, H. (2025) · ACS Omega · doi:10.1021/acsomega.4c06840 · Cited by 8
Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study
Makarova, M. V., Krettek, A., Valkov, М. Y., & Grjibovski, A. M. (2013) · International Journal of Circumpolar Health · doi:10.3402/ijch.v72i0.20282 · Cited by 6
Hepatitis B virus in Egypt: the whole story
Abdelhamed, W., & El‐Kassas, M. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00362-3 · Cited by 6
Sarcopenia as a Predictive Factor for Recurrence of Hepatocellular Carcinoma Following Radiofrequency Ablation
Jaruvongvanich, V., Thamtorawat, S., Saiviroonporn, P., Pisanuwongse, A., & Siriwanarangsun, P. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.4.1143 · Cited by 6
Effect of Hepatitis B Virus X Gene on the Expression Level of p53 Gene using Hep G2 Cell Line.
Kordestani, R., Mirshafiee, H., Hosseini, S. M., & Sharifi, Z. (2014) · Europe PMC (PubMed Central) · Cited by 6
SYSTEMATIC REVIEW: BURDEN OF GASTROINTESTINAL AND LIVER DISEASES IN MIDDLE EAST AND NORTH AFRICA: RESULTS OF GLOBAL BURDEN OF DISEASES STUDY FROM 1990 TO 2010
Sepanlou, S. G., Malekzadeh, F., Delavari, F., Naghavi, M., Hossein, F. M., Shahraz, S., Moradi‐Lakeh, M., Reza, M., Poustchi, H., & Pourshams, A. (2015) · Cited by 6
Oncogenic Viruses
Kumar, M., Seema, K., Sharma, A. K., Prasad, A., Sinha, N., Bhuttoo, Z. A., & Kumari, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819400-3.00018-1 · Cited by 6
Hepatitis B Vaccines
Ward, J. W., Wanlapakorn, N., Poovorawan, Y., & Shouval, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00027-x · Cited by 5

Authors: Kew, M. C.
Affiliations: University of Cape Town (ZA)
Corresponding author: Kew, M.C.
Venue: Pathologie Biologie
Publisher: Elsevier BV
Published: 2010-08
Volume: 58
Issue: 4
Pages: 273-277
ISSN: 0369-8114 (ISSN-L)
DOI: 10.1016/j.patbio.2010.01.005
OpenAlex: W1995958786
Cited by: 275
References: 63
Citations by year: 2026: 6 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 11 · 2021: 16 · 2020: 13 · 2019: 26 · 2018: 12 · 2017: 21 · 2016: 22 · 2015: 28 · 2014: 36 · 2013: 27 · 2012: 25
FWCI: 15.59
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Pathologie Biologie (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Keywords: chronic hepatitis B, hepatocellular carcinoma, HBV genotypes, HBV mutations, aflatoxin B1, liver cirrhosis, hepatitis C coinfection, cancer incidence and mortality, risk factors, developing countries
MeSH terms: Female, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Risk, Sex Factors, Aflatoxin B1, Hepatitis B Vaccines, Endemic Diseases, Hepatitis B, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks